Label: UQORA MAXIMUM UTI PAIN RELIEF- phenazopyridine hydrochloride tablet

  • NDC Code(s): 73712-114-12, 73712-114-24
  • Packager: Bonafide Health, LLC dba Uqora
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated October 27, 2025

If you are a consumer or patient please visit this version.

  • Active ingredient (in each tablet)

    Phenazopyridine Hydrochloride 99.5 mg .

  • Purpose

    Urinary Tract Analgesic

  • Use

    Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions.

  • Warnings

    Do not exceed recommended dosage

    Do not use: if you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.

    Ask doctor before use if you have

    ■ kidney disease
    ■ allergies to foods, preservatives or dyes
    ■ had a hypersensitive reaction to phenazopyridine

    When using this product

    ■ stomach upset may occur, taking this product with or after meals may reduce stomach upset
    ■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.

    ----

    ■ Long-term administration of phenazopyridine hydrochloride has induced neoplasia in rats (large intestine) andmice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has beenreported, adequate epidemiological studies along these lines have not been conducted.

    Stop use and ask doctor if

    ■ your symptoms last for more than 2 days
    ■ you suspect you are having an adverse reaction to the medication

    If pregnant or breast feeding, ask a health professional before use.

    Keep out of reach of children. In case of an overdose, get medical help or contact a Poison Control Center right away 1-800-222-1222.

  • Directions

    Adults and children 12 years and over:
    ■ take 2 tablets 3 times daily with a full glass of water, with or after meals as needed

    ■ Do not use for more than 2 days (12 tablets) without consulting a doctor.

    Children under 12 years:

    ■ consult a doctor


  • Other information

    ■ this product may stain contact lenses ■ this product can interfere with laboratorytests including urine, glucose (sugar), and ketones tests ■ store at room temperature 15°-30°C (59°-86°F) in adry place and protect from light ■ Tamper evident: tablets sealed in blisters. Do not use if blister foil or seal isopen or damaged

  • Inactive ingredients

    corn starch, croscarmellose sodium, hypromellose, lactose, magnesium stearate,microcrystalline cellulose, polyethylene glycol, polyvinylpyrrolidone, pregelatinized starch, silicon dioxide, sodiumstarch glycolate, talc and triacetin

  • PRINCIPAL DISPLAY PANEL

    MAX STRENGTH MOST POWERFUL DOSE WITHOUT RX

    uqora

    FOUNDED BY A UTI SUFFERER

    UTI PAIN RELIEF

    MAX STRENGTH

    FAST TARGETED RELIEF FOR

    Burning

    Pain & discomfort at the source unlike general pain relievers

    Urgency

    2 Day Supply

    12 tablets

    99.5 mg Phenazopyridine Hydrochloride

    Not intended to replace medical care

    1

    2

  • INGREDIENTS AND APPEARANCE
    UQORA MAXIMUM UTI PAIN RELIEF 
    phenazopyridine hydrochloride tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73712-114
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17) (PHENAZOPYRIDINE - UNII:K2J09EMJ52) PHENAZOPYRIDINE HYDROCHLORIDE99.5 mg
    Inactive Ingredients
    Ingredient NameStrength
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)  
    TALC (UNII: 7SEV7J4R1U)  
    POVIDONE (UNII: FZ989GH94E)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    TRIACETIN (UNII: XHX3C3X673)  
    LACTOSE (UNII: J2B2A4N98G)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    Product Characteristics
    ColorbrownScoreno score
    ShapeOVALSize9mm
    FlavorImprint Code p99
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:73712-114-241 in 1 CARTON10/27/2025
    124 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:73712-114-121 in 1 CARTON10/27/2025
    212 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other10/27/2025
    Labeler - Bonafide Health, LLC dba Uqora (118327455)
    Establishment
    NameAddressID/FEIBusiness Operations
    Pharbest Pharmaceuticals, Inc.557054835manufacture(73712-114)